Found: 9
Select item for more details and to access through your institution.
First Infusion Reactions are Mediated by FcγRIIIb and Neutrophils.
- Published in:
- Pharmaceutical Research, 2018, v. 35, n. 9, p. 1, doi. 10.1007/s11095-018-2448-8
- By:
- Publication type:
- Article
Toward Understanding the Mechanism of Chromophore-assisted Laser Inactivation-Evidence for the Primary Photochemical Steps.
- Published in:
- Photochemistry & Photobiology, 2005, v. 81, n. 2, p. 358, doi. 10.1111/j.1751-1097.2005.tb00195.x
- By:
- Publication type:
- Article
Circular RNAs With Efficacy in Preclinical In Vitro and In Vivo Models of Esophageal Squamous Cell Carcinoma.
- Published in:
- Cancer Genomics & Proteomics (1109-6535), 2022, v. 19, n. 3, p. 283, doi. 10.21873/cgp.20320
- By:
- Publication type:
- Article
A Human Blood-Brain Barrier Transcytosis Assay Reveals Antibody Transcytosis Influenced by pH-Dependent Receptor Binding.
- Published in:
- PLoS ONE, 2014, v. 9, n. 4, p. 1, doi. 10.1371/journal.pone.0096340
- By:
- Publication type:
- Article
Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding
- Published in:
- PLoS ONE, 2013, v. 8, n. 5, p. 1, doi. 10.1371/journal.pone.0062697
- By:
- Publication type:
- Article
Functional proteomics using chromophore- assisted laser inactivation.
- Published in:
- Proteomics, 2002, v. 2, n. 3, p. 241, doi. 10.1002/1615-9861(200203)2:3<241::AID-PROT241>3.0.CO;2-7
- By:
- Publication type:
- Article
Investigating receptor-mediated antibody transcytosis using blood–brain barrier organoid arrays.
- Published in:
- Fluids & Barriers of the CNS, 2021, v. 18, n. 1, p. 1, doi. 10.1186/s12987-021-00276-x
- By:
- Publication type:
- Article
Transcytosis of payloads that are non-covalently complexed to bispecific antibodies across the hCMEC/D3 blood-brain barrier model.
- Published in:
- Biological Chemistry, 2018, v. 399, n. 7, p. 711, doi. 10.1515/hsz-2017-0311
- By:
- Publication type:
- Article
Brain Shuttle Neprilysin reduces central Amyloid-β levels.
- Published in:
- PLoS ONE, 2020, v. 15, n. 3, p. 1, doi. 10.1371/journal.pone.0229850
- By:
- Publication type:
- Article